β2-microglobulin has a different regulatory molecular mechanism between ER(+) and ER(−) breast cancer with HER2(−)

BACKGROUND: Previous studies have demonstrated that β2-microglobulin (β2M) promotes the growth and survival of a variety of cancer cells and has different regulatory effects on the expression of Bcl-2 and HER2 in HER2(−) breast cancer cells. However, β2M-mediated signaling in ER(+) and ER(−) breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Dandan, Li, Kesheng, Du, Huifen, Yang, Suisheng, Yang, Rong, Xu, Yang, Lian, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417228/
https://www.ncbi.nlm.nih.gov/pubmed/30866857
http://dx.doi.org/10.1186/s12885-019-5410-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417228/
https://www.ncbi.nlm.nih.gov/pubmed/30866857
http://dx.doi.org/10.1186/s12885-019-5410-1

Ejemplares similares